Neurological diseases are frequent in older adults, affecting around 55% of people aged 55 and older. They are associated with a high risk for adverse health outcomes, including mortality, disability, institutionalization, and hospitalization. Neurological diseases, like dementia and Parkinson’s disease, and strokes and headaches, are frequently encountered n eurological diseases in el derly patien ts. Neuromodula tion is an in tracranial, el ectrical neuromodulation therapy that has FDA approval for the treatment for several of the neurological diseases, such as bladder control, headache, tremors, chronic pain, stroke, minimally conscious state, and spinal cord injury, which are most found in the elderly population. There are multiple ways through which funding organizations, research teams, and non-profit organizations are collaborating with consumers to raise the awareness regarding this neurological diseases, globally. The educational campaigns also play a demanding role in making patients and families aware of the neurological diseases, particularly in the middle and low-income nations, where the focus of the government and healthcare facilities are geared more toward major disorders, such as Parkinson’s disease and Alzheimer's disease.

1. INTRODUCTION 

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY 

4. MARKET DYNAMICS 

5. MARKET SEGMENTATION 

6. COMPANY PROFILES AND COMPETITIVE LANDSCAPE 

7. MARKET OPPORTUNITIES AND FUTURE TRENDS